Kiniksa Pharmaceuticals International Plc (KNSA) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Kiniksa Pharmaceuticals International Plc  (NASDAQ: KNSA)

Kiniksa Pharmaceuticals International Plc

Officers & Directors


Kimberly J. Popovits
Director -

Stephen R. Biggar
Director -

Mark Ragosa
Chief Financial Officer - (principal financial officer)

Barry D. Quart
Director -

Thomas R. Malley
Director -

G. Bradley Cole
Director -

Sanj K. Patel
Chief Executive Officer and Chairman of the Board of Directors - (principal executive officer)

Richard S. Levy
Director -

Tracey L. McCain
Director -


Boston, Massachusetts -

Felix J. Baker
Lead Independent Director -

Michael R. Megna
Group VP, Finance and Chief Accounting Officer - (principal accounting officer) ,

Kiniksa Pharmaceuticals International Plc currently has 366 employees.






KNSA Management Effectiveness KNSA Revenue per Employee KNSA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.